Rhenman & Partners Asset Management AB - Q4 2017 holdings

$740 Million is the total value of Rhenman & Partners Asset Management AB's 95 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .

 Value Shares↓ Weighting
HAL  Halliburton Co (Hg Co)$545,000
+6.2%
11,1440.0%0.07%
+13.8%
XOM  Exxon Mobil Corp$476,000
+1.9%
5,6960.0%0.06%
+6.7%
MSFT  Microsoft Corp$410,000
+14.8%
4,7930.0%0.06%
+19.6%
PFE  Pfizer Inc$377,000
+1.3%
10,4220.0%0.05%
+8.5%
F  Ford Motor Co$355,000
+4.4%
28,4040.0%0.05%
+11.6%
QCOM  Qualcomm Inc$344,000
+23.7%
5,3680.0%0.05%
+31.4%
BUD  Anheuser-Busch InBev SA ADR spons repr 1 Sharesponsored adr$313,000
-6.6%
2,8060.0%0.04%
-2.3%
IBM  IBM Corp$271,000
+5.9%
1,7660.0%0.04%
+12.1%
SYMC  Symantec Corp$263,000
-14.3%
9,3590.0%0.04%
-7.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-01-19
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Export Rhenman & Partners Asset Management AB's holdings